Early research (Phase 1)Looking for participantsNCT07159126What this trial is testingDS3610a in Participants With Advanced Solid TumorWho this might be right forSolid TumorsMetastatic Solid Tumors Daiichi Sankyo 70
Not applicableStudy completedNCT01987726What this trial is testingComprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid TumorsWho this might be right forRecurrent Breast CancerRecurrent Colon CancerRecurrent Rectal Cancer+5 more Ohio State University Comprehensive Cancer Center 150
Early research (Phase 1)Study completedNCT03150810What this trial is testingStudy to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors BeiGene 139
Early research (Phase 1)Study completedNCT00532090What this trial is testingA Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.Who this might be right forNeoplasms Hoffmann-La Roche 110
Early research (Phase 1)Not Yet RecruitingNCT07797907What this trial is testingThis Clinical Study is to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Antitumor Activity of BD200 in Participants With Advanced or Metastatic Cancer.Who this might be right forSolid Tumor (Phase I) Biolojic Design Ltd. 110
Not applicableLooking for participantsNCT07584824What this trial is testingIs the 1939 Cancer Act Fit for Purpose in the Modern Technology Era?Who this might be right forCancerCancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or PalliativeCancer (Solid Tumors)+2 more Royal Cornwall Hospitals Trust 50
Early research (Phase 1)Study completedNCT01928459What this trial is testingPhase 1b Trial of BGJ398/BYL719 in Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Solid Tumors Novartis Pharmaceuticals 62
Testing effectiveness (Phase 2)Study completedNCT02280317What this trial is testingDose Finding Safety Study of VAL201 in Cancer PatientsWho this might be right forStage III Prostate CarcinomaStage IV Prostate Carcinoma ValiRx Plc 12
Early research (Phase 1)Ended earlyNCT03685591What this trial is testingPF-06952229 Treatment in Adult Patients With Advanced Solid TumorsWho this might be right forBreast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more Pfizer 49
Early research (Phase 1)Study completedNCT02159989What this trial is testingSapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdvanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Early research (Phase 1)UnknownNCT05989724What this trial is testingA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorBreast CancerPancreatic Cancer+2 more Qurgen Inc. 150
Early research (Phase 1)Ended earlyNCT01891669What this trial is testingPF-06263507 In Patients With Advanced Solid TumorsWho this might be right forNeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more Pfizer 26
Early research (Phase 1)Study completedNCT06056024What this trial is testingTest How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and OesophagusWho this might be right forSolid Tumor, KRAS Mutation Boehringer Ingelheim 47
Early research (Phase 1)Study completedNCT00741403What this trial is testingA Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced MalignanciesWho this might be right forAdvanced CancerMetastatic CancerLymphoma+2 more Cornerstone Pharmaceuticals 39
Early research (Phase 1)Looking for participantsNCT05614739What this trial is testingFORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3Who this might be right forUrinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms Eli Lilly and Company 677
Early research (Phase 1)Looking for participantsNCT07514065What this trial is testingTSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary EfficacyWho this might be right forMetastatic Castration-Resistant Prostate Cancer Patients Tasly Pharmaceutical Group Co., Ltd 78
Early research (Phase 1)Study completedNCT01032681What this trial is testingEMD 521873 in Advanced Solid Tumors, MTD FindingWho this might be right forNon-Hodgkin Lymphoma Merck KGaA, Darmstadt, Germany 66
Testing effectiveness (Phase 2)Looking for participantsNCT05498428What this trial is testingAmivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-small-Cell Lung Janssen Research & Development, LLC 520
Early research (Phase 1)Study completedNCT00747734What this trial is testingMNRP1685A in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Cancers Genentech, Inc. 35